Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 889-900 of 4,306
Drug study icon
CompletedNCT05406440

Elpipodect (MK-8189) in people with Schizophrenia (MK-8189-014)

This study is completed in the United States. It is testing elpipodect for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00210691

Long-acting Injectable Risperidone for schizophrenia

This study is completed. It is testing Long-acting Injectable Risperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01307800

LY2140023 in people with Schizophrenia

This study was terminated in the United States, in Mexico, in Russia, .... It is testing LY2140023 for schizophrenia.

Multiple locations, including Wichita
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Mexico, Russia, ...
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT01052103

LY2140023 in Schizophrenia people with Prominent Negative Symptoms

This study is completed in the United States, in Israel, in Italy, .... It is testing LY2140023 for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Israel, Italy, ...
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT05953740

MK-5720 in people with Schizophrenia (MK-5720-001)

This study is completed in the United States. It is testing MK-5720 for schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00216476

Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in schizophrenia

This study is completed in France, in the United Kingdom, in Austria, .... It is testing Long-acting Injectable Risperidone and Quetiapine Tablets for schizophrenia.

Multiple locations, including Hall in Tirol
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
France, United Kingdom, Austria, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT01354353

Safety study of safety and Tolerability in schizophrenia

This study is completed in the United States. It is testing safety and Tolerability for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT01617187

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Drug study icon
CompletedNCT04115319

Safety study of investigational Drug in schizophrenia

This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Romania, Russia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04510298

Safety study of Safety, PK, and Exploratory Efficacy of SP-624 in schizophrenia

This study is completed in the United States. It is testing Safety, PK, and Exploratory Efficacy of SP-624 for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.